全文获取类型
收费全文 | 6879篇 |
免费 | 491篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 124篇 |
妇产科学 | 107篇 |
基础医学 | 882篇 |
口腔科学 | 55篇 |
临床医学 | 759篇 |
内科学 | 1834篇 |
皮肤病学 | 94篇 |
神经病学 | 708篇 |
特种医学 | 248篇 |
外科学 | 961篇 |
综合类 | 54篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 397篇 |
眼科学 | 105篇 |
药学 | 444篇 |
中国医学 | 5篇 |
肿瘤学 | 574篇 |
出版年
2023年 | 35篇 |
2022年 | 51篇 |
2021年 | 144篇 |
2020年 | 97篇 |
2019年 | 144篇 |
2018年 | 187篇 |
2017年 | 123篇 |
2016年 | 138篇 |
2015年 | 174篇 |
2014年 | 226篇 |
2013年 | 320篇 |
2012年 | 536篇 |
2011年 | 519篇 |
2010年 | 317篇 |
2009年 | 296篇 |
2008年 | 462篇 |
2007年 | 506篇 |
2006年 | 414篇 |
2005年 | 465篇 |
2004年 | 476篇 |
2003年 | 398篇 |
2002年 | 371篇 |
2001年 | 64篇 |
2000年 | 58篇 |
1999年 | 51篇 |
1998年 | 83篇 |
1997年 | 72篇 |
1996年 | 54篇 |
1995年 | 60篇 |
1994年 | 53篇 |
1993年 | 39篇 |
1992年 | 45篇 |
1991年 | 34篇 |
1990年 | 21篇 |
1989年 | 27篇 |
1988年 | 22篇 |
1987年 | 26篇 |
1986年 | 22篇 |
1985年 | 25篇 |
1984年 | 17篇 |
1983年 | 20篇 |
1982年 | 14篇 |
1981年 | 14篇 |
1980年 | 15篇 |
1978年 | 16篇 |
1977年 | 15篇 |
1976年 | 14篇 |
1974年 | 21篇 |
1973年 | 14篇 |
1971年 | 15篇 |
排序方式: 共有7421条查询结果,搜索用时 694 毫秒
101.
102.
103.
104.
105.
106.
Wolfgang Schoels MD David Steinhaus MD W. Ben Johnson MD Gilles OHara MD Joerg O. Schwab MD Inge Jenniskens MSc Paul J. DeGroot MS Feng Tang PhD Erhard Helmling MD EnTrust Clinical Study Investigators 《Heart rhythm》2007,4(7):879-885
BACKGROUND: Previous studies in implantable cardioverter-defibrillator (ICD) patients demonstrated the efficacy and safety of antitachycardia pacing (ATP) for rapid ventricular tachycardias (VT). To prevent shock delay in case of ATP failure, a new feature (ATP during charging) was developed to deliver ATP for rapid VT while charging for shock. OBJECTIVE: The purpose of this study was to determine the efficacy and safety of this new feature. METHODS: In a prospective, nonrandomized trial, patients with standard ICD indication received an EnTrust ICD. VT and ventricular fibrillation (VF) episodes were reviewed for appropriate detection, ATP success, rhythm acceleration, and related symptoms. RESULTS: In 421 implanted patients, 116 VF episodes occurred in 37 patients. Eighty-four (72%) episodes received ATP during or before charging. ATP prevented a shock in 58 (69%) of 84 episodes in 15 patients. ATP stopped significantly more monomorphic (77%) than polymorphic VTs (44%, P = .05). Five (6%) episodes accelerated after ATP but were terminated by the backup shock(s). No symptoms were related to ATP during charging. In four patients, 38 charges were saved by delivering ATP before charging. Of 98 induced VF episodes, 28% were successfully terminated by ATP versus 69% for spontaneous episodes (P <.01). CONCLUSION: Most VTs detected in the VF zone can be painlessly terminated by ATP delivered during charging, with a low risk of acceleration or symptoms. ATP before charging allows delivery of two ATP attempts before shock in the same time that would otherwise be required to deliver only one ATP plus a shock. It also offers potential battery energy savings. 相似文献
107.
108.
Huong DL Wechsler B Vauthier-Brouzes D Duhaut P Costedoat N Lefebvre G Piette JC 《Seminars in arthritis and rheumatism》2002,32(3):174-188
OBJECTIVE: To analyze the results and complications of ovulation induction therapy (OIT) in women with systemic lupus erythematosus (SLE) and/or the antiphospholipid syndrome (APS). METHODS: A retrospective study of 21 women followed in a single tertiary-referral French center who underwent 114 OIT cycles with or without in vitro fertilization and embryo transfer (IVFET). RESULTS: Before OIT, SLE was present in 6 women, APS in 3, SLE-related APS in 3, and discoid lupus in 1. Eight women had no identified disease and underwent 36 cycles of OIT. Diagnosis (SLE, n = 3; primary APS, n = 5) was made after OIT complication: spontaneous abortion (n = 5), SLE flare (n = 2), and thrombophlebitis (n = 1). Five women with known disease intentionally concealed their history from their gynecologists and underwent 34 cycles. Forty-four cycles were planned in 11 women, in 3 of them after complications of prior OIT performed without particular therapy and monitoring. Eighteen pregnancies occurred, which ended in 9 live births, 4 fetal deaths, and 5 embryonic losses. The pregnancy rate was higher with gonadotropin and/or gonadotropin-releasing hormone analog (GnRHa) (25% of cycles) than with clomiphene (4% of cycles, P <.0001). When the gynecologists did not know the underlying disease, three-quarters of pregnancies induced by OIT with IVFET ended in embryonic losses or fetal deaths. In contrast, 6 of 7 pregnancies induced by planned OIT with IVFET ended in live births (P <.0001). Phlebothromboses were observed only with gonadotropin treatment. The SLE flare rate was higher with gonadotropin and/or GnRHa (27% of cycle) than with clomiphene (6%, NS). It also was higher (30%) when the gynecologists did not know the underlying disease than in the planned procedures (10%, NS). CONCLUSIONS: The OIT may precipitate SLE or APS. A careful review of the patient's history and appropriate laboratory tests should be undertaken before OIT. Clomiphene complications are rare. When gonadotropins are prescribed, preventive anti-inflammatory therapy should be considered in women with SLE, in addition to heparin and/or anti-aggregant therapy in patients with asymptomatic anti-phospholipid antibodies or prior thrombotic events. 相似文献
109.
110.
Laurence Dangers Jonathan Giovannelli Gilles Mangiapan Mikael Alves Naïke Bigé Jonathan Messika Elise Morawiec Mathilde Neuville Christophe Cracco Gaëtan Béduneau Nicolas Terzi Isabelle Huet Xavier Dhalluin Nathalie Bautin Jean-Jacques Quiot Corinne Appere-de Vecchi Thomas Similowski Cécile Chenivesse 《Chest》2021,159(4):1621-1629